System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Yasuyuki Kojima

Oncology — Showa University Medical School Nursing College, Japan

LeadR Profile

Yasuyuki Kojima Showa University Medical School Nursing College Japan
237 ScienceLeadR Reputation 237

Unlock

Register Login
Network Map

Oncology

Subspecialties: Urology - Dermatology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2003 - 2026
Source: PubMed

Showa University Medical School Nursing College

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 101

Citations

Citations: 1 525 1st author: 16 Last author: 2 Unique author: 0

Main journals

Breast Cancer 18
Ann Oncol 5
Breast Cancer Res Treat 5
Hinyokika Kiyo 5
J Clin Oncol 5

Best Journals

Ann Oncol 2
J Clin Oncol 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Trastuzumab deruxtecan rechallenge in HER2-positive metastatic breast cancer: EN-SEMBLE.
breast neoplasms, progression-free survival, neoplasms, breast, therapeutics, trastuzumab		Breast20261
Efficacy and safety of eribulin mesylate vs. docetaxel or paclitaxel, combined with trastuzumab and pertuzumab, as first-line treatment for HER2-positive locally advanced or metastatic breast cancer: updated subgroup analyses of JBCRG-M06/EMERALD.
mesylates, safety, breast neoplasms, docetaxel, paclitaxel, neoplasms, breast, therapeutics, trastuzumab		Breast Cancer Res Treat20260
Quality-of-life assessment in the randomized JBCRG-M06/EMERALD study of eribulin plus dual HER2 blockade in HER2-positive locally advanced or metastatic breast cancer.
quality of life, confidence intervals, breast neoplasms, neoplasms, breast, therapeutics, trastuzumab		Breast Cancer20260
Prevalence and clinical significance of germline pathogenic variants identified by multigene panel testing in high-risk Japanese patients with breast cancer.
research design, genes, genetic testing, breast neoplasms, ovary, neoplasms, insurance, breast, prevalence		Breast Cancer20260
Safety and effectiveness of post-trastuzumab deruxtecan regimens in patients with HER2-positive metastatic breast cancer who discontinued trastuzumab deruxtecan due to interstitial lung disease.
lung, safety, breast neoplasms, neoplasms, breast, therapeutics, lung diseases, trastuzumab, lung diseases, interstitial		Breast20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 1

By status:

Completed 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 1
multicentric5to9 0
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS